Screening for Social Weaknesses and Coordination Course of Cancer Patients
NCT ID: NCT02369783
Last Updated: 2016-02-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
71 participants
INTERVENTIONAL
2014-07-31
2015-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This tool will be dematerialized on a tablet. The answers will be then processed by a decision support algorithm, which automatically send an alert to detection of social fragility of the patient to the nurse navigators.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Tool for the Detection of Oncogeriatric Fragility in Patients Aged ≥75 Years Undergoing Oncological Treatment.(D-FOG)
NCT03261128
Facilitating Advance Care Planning Discussions for People With Advance Cancer
NCT06061965
Improving Communication in Older Cancer Patients and Their Caregivers
NCT02107443
Web-based Collaborative Care Intervention Study
NCT02939755
Patient-caregiver Communication Intervention for Prognostic Understanding
NCT03833817
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Questionnaire and interview
The patient complete the questionnaire on the tablet to better know their social situation and any difficulties. Then, he will be interview during thirty minutes with a social worker and a nurse navigator. At the end of this intervention we will be offered to the patient monitoring and appropriate resources to its situation.
Questionnaire and interview
The aim is to detect social fragility.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionnaire and interview
The aim is to detect social fragility.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who can read French or patients who can not read French, but accepting the translation by a close friend or family
* Patient having signed a free and informed consent
Exclusion Criteria
* Patient can not read French without possibility of translation by a close friend or family
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut de Cancérologie de la Loire
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Franck Chauvin, PhD-MD
Role: STUDY_DIRECTOR
INSTITUT DE CANCEROLOGIE DE LA LOIRE
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institut de Cancerologie de la Loire
Saint-Priest-en-Jarez, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2014-05
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.